{"id":"NCT00344032","sponsor":"GlaxoSmithKline","briefTitle":"Evaluation of the Immune and Safety Response of GlaxoSmithKline (GSK) Biologicals' HPV Vaccine in Healthy Indian Women","officialTitle":"Phase IIIb, Double-blind, Randomized, Controlled Study to Evaluate the Immunogenicity and Safety of GSK Biologicals' HPV-16/18 VLP/AS04 Vaccine Administered Intramuscularly at 0, 1, 6 Months in Healthy Indian Female Subjects Aged 18-35 Yrs","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2006-07-28","primaryCompletion":"2007-12-01","completion":"2007-12-04","firstPosted":"2006-06-26","resultsPosted":"2009-12-15","lastUpdate":"2018-07-20"},"enrollment":354,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"DOUBLE","primaryPurpose":"PREVENTION"},"conditions":["Infections, Papillomavirus"],"interventions":[{"type":"BIOLOGICAL","name":"Placebo","otherNames":[]},{"type":"BIOLOGICAL","name":"HPV-16/18 VLP/AS04 Vaccine (Cervarix TM)","otherNames":["GSK Biologicals' HPV-16/18 VLP/AS04 vaccine"]}],"arms":[{"label":"Cervarix","type":"EXPERIMENTAL"},{"label":"Placebo","type":"PLACEBO_COMPARATOR"}],"summary":"Human papillomavirus infection has clearly been recognized as the cause of cervical cancer. Indeed, the infection of the cervix by certain oncogenic types of HPV, if not cleared , can lead over time to cervical cancer in women . This study will evaluate the immune response induced by the HPV-16/18 L1/AS04 vaccine and the safety of the vaccine.\n\nThe Protocol Posting has been updated in order to comply with the FDA Amendment Act, Sep 2007.","primaryOutcome":{"measure":"Number of Subjects Who Seroconverted for Anti-human Papilloma Virus 16 (Anti-HPV-16) and Anti-human Papilloma Virus 18 (Anti-HPV-18) Antibodies","timeFrame":"At Month 7","effectByArm":[{"arm":"Cervarix","deltaMin":124,"sd":null},{"arm":"Placebo","deltaMin":16,"sd":null}],"pValues":[]},"eligibility":{"minAge":"18 Years","sex":"FEMALE","healthyVolunteers":true,"inclusionCount":6,"exclusionCount":14},"locations":{"siteCount":4,"countries":["India"]},"refs":{"pmids":["20178538","18845199"],"seeAlso":["https://www.clinicalstudydatarequest.com"]},"adverseEventsSummary":{"seriousAny":{"events":2,"n":176},"commonTop":["Pain","Fatigue","Headache","Swelling","Fever (above 37.5 degree Celsius)"]}}